StonvexLoading…
StonvexStonvexStonvexCore line items from ASUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $37.72M | $42.76M | $101.23M | $64.98M | $34.85M |
Operating Income | Not available | $2.33M | $-10.17M | $-6.67M | $-2.02M |
Net Income | Not available | $625.00K | $-13.88M | $-6.12M | $-2.40M |
EPS (Diluted) | $0.12 | $0.02 | $-0.51 | $-0.31 | $-0.09 |
Total Assets | Not available | $518.68M | $447.08M | $505.56M | $498.94M |
Total Liabilities | Not available | $318.56M | $253.99M | $311.31M | $301.28M |
Cash & Equivalents | Not available | $19.22M | $21.52M | $66.00M | $14.08M |
Free Cash Flow OCF − CapEx | Not available | $2.49M | $10.41M | $4.76M | $1.80M |
Shares Outstanding | Not available | 28.64M | 27.73M | 27.36M | 27.12M |